1.89
-0.03(-1.56%)
Currency In USD
| Previous Close | 1.92 |
| Open | 1.91 |
| Day High | 1.97 |
| Day Low | 1.87 |
| 52-Week High | 10.3 |
| 52-Week Low | 1.86 |
| Volume | 509,515 |
| Average Volume | 771,345 |
| Market Cap | 120.43M |
| PE | -2.36 |
| EPS | -0.8 |
| Moving Average 50 Days | 2.52 |
| Moving Average 200 Days | 5.16 |
| Change | -0.03 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $74.03 as of February 21, 2026 at a share price of $1.89. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $86.34 as of February 21, 2026 at a share price of $1.89.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
GlobeNewswire Inc.
Feb 12, 2026 10:13 PM GMT
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
GlobeNewswire Inc.
Jan 13, 2026 12:05 PM GMT
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
GlobeNewswire Inc.
Jan 08, 2026 9:05 PM GMT
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor